Federal officials warn states against restricting Medicaid access to hepatitis C cure

November 04, 2015

Confronting the consequences of high-priced drugs, the Obama administration reminded states they cannot legally restrict access for Medicaid beneficiaries to cures for hepatitis C. The administration questioned requirements by some states that patients must have advanced liver disease first before they can get the cure. Federal officials also cited requirements by some states that patients abstain from illegal drugs and alcohol as condition of getting treatment. CMS also sent letters to several drug manufacturers, requesting details of what they are doing to make their medications more affordable. Among the companies getting federal letters was Gilead Sciences.
Related News:
Federal officials warn states about hepatitis C drug restrictions - The Wall Street Journal
Administration wades further into drug price debate - The Hill